Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

SRZNW SURROZEN INC C/WTS 01/08/2031 (TO PUR COM)

Watchlist
0.0560.0000.00%
Close  01/27 16:00 ET
High
0.000
Open
0.056
Turnover
0.00
Low
0.000
Pre Close
0.056
Volume
0.00
Market Cap
0
P/E(TTM)
0.00
52wk High
0.554
Shares
0
P/E(Static)
0.00
52wk Low
0.021
Float Cap
0
Bid/Ask %
0.00%
Historical High
3.000
Shs Float
0
Volume Ratio
0.00
Historical Low
0.021
Dividend TTM
--
Div Yield TTM
--
P/B
0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
--
Lot Size
1
Float Cap
0
Bid/Ask %
0.00%
Historical High
3.000
Shs Float
0
Volume Ratio
0.00
Historical Low
0.021
Dividend TTM
--
P/B
0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
--
Lot Size
1
Price Forecast

News

Comment

No Data

Company Overview More
Surrozen, Inc. is a preclinical stage biotechnology company, which engages in discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. It is also focused on developing tissue-specific antibodies designed to engage the body's existing biological repair mechanisms with potential application across multiple disease areas, including inflammatory bowel disease, hepatitis, eye diseases, hearing loss, lung and airway diseases, and certain neurological disorders. The company was founded on August 12, 2015 and is headquartered in South San Francisco, CA.
CEO: Mr. Craig C. Parker
Market: NASDAQ
Listing Date: 08/12/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist